RS
ALNY icon

Ricky Sandler’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ricky Sandler’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-125,979
Closed -$16.4M – 69
2020
Q4 		$16.4M Buy
125,979
+23,710
+23% +$3.17M 0.15% 74
2020
Q3 		$14.9M Sell
102,269
-79,304
-44% -$11.3M 0.15% 74
2020
Q2 		$26.9M Buy
+181,573
New +$24.5M 0.27% 65

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ricky Sandler's ALNY Position: Q1 2021 in Review

Ricky Sandler sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2021, closing a stake of 125,979 shares — an estimated $16.4M sold.

Ricky Sandler first reported a position in ALNY in Q2 2020 and held it in 3 quarters. The position peaked at $26.9M in Q2 2020. 391 funds tracked by Wall St. Rank hold ALNY as of Q1 2021.

  • Ricky Sandler reported no remaining Alnylam Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Ricky Sandler sold 125,979 Alnylam Pharmaceuticals shares in Q1 2021, an estimated $16.4M.
  • Ricky Sandler first reported a position in Alnylam Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Ricky Sandler's Alnylam Pharmaceuticals position peaked at $26.9M in Q2 2020.
  • 391 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2021.

Based on Eminence Capital's 13F filing for Q1 2021, filed 17 May 2021.